Anzeige
Mehr »
Dienstag, 01.07.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
480 Leser
Artikel bewerten:
(2)

UAE IVF Drugs and Food Supplements Market to Surpass US$ 33.9 Million by 2030, Says Coherent Market Insights

SEATTLE, Feb. 25, 2022 /PRNewswire/ -- According to Coherent Market Insights, the UAE IVF drugs and food supplements market is estimated to be valued at US$ 20.4 million in 2022 and is expected to exhibit a CAGR of 6.6% during the forecast period (2022-2030).

Coherent Market Insights Logo

Key Trends and Analysis of the UAE IVF Drugs and Food Supplements:

The growing awareness and educational programs conducted in the country is expected to boost the UAE IVF drugs and food supplements market over the forecast period. For instance, in September 2019, the 2nd Fertility Middle East Conference were conducted at Sofitel Dubai Downtown by HealthPlus Fertility Centers, a part of United Eastern Medical Services (UEMedical) and accredited by Dubai Health Authority for more than 400 physicians, specialists, IVF lab technicians, pharmacists, and technicians from different fertility centers and hospitals in the UAE and the region. The aim of this conference was to discuss the latest fertility treatment techniques and advanced technologies and present the latest scientific research on fertility issues such as pregnancy complications, infertility problems which is expected to help IVF specialty doctors to provide IVF Drugs and Food Supplements to patients in upcoming years as the current status in UAE is for year 2019, according to the World Population review stated that the fertility rate in year 2019 was 2.3% and ranks at 88 in overall world which expected to increase the growth of IVF drugs and food supplements market in region.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4939

Key Market Takeaways:

The UAE IVF drugs and food supplements market is expected to exhibit a CAGR of 6.6% during the forecast period, owing to the strategies by market players to address to patients issues related to infertility, which is expected to propel growth of the market during the forecast period. For instance, on October 15, 2021, Organon, a pharmaceutical company, launched a new website for Fertility Journey that helps inform and empower people with resources and information needed to navigate the process of fertility care. The website aims to meet people wherever they are on their fertility journey and equip them with knowledge and questions for consideration to feel prepared and empowered throughout their journey.

Key players operating in the UAE IVF drugs and food supplements market include Shinelife, Adorefem, LG Chem, Adorshea, Biofield Pharma, Medibyte, Mestra Pharma, Dr. D Pharma, Abbott, Zydus, Takeda Pharmaceutical Company Limited, Merck KGaA, and Ferring B.V.

Request for Customization @ https://www.coherentmarketinsights.com/insight/request-customization/4939

Detailed Segmentation:

UAE IVF Drugs and Food Supplements Market, by Product Type:

  • Drugs
    • Clomiphene
    • Injectable Hormones
      • Human chorionic gonadotropin (hCG)
      • Follicle-stimulating hormone (FSH)
      • Human menopausal gonadotropin (hMG)
      • Gonadotropin-releasing hormone (GnRH)
      • GnRH agonist
      • GonGnRH antagonist
  • Food Supplements

UAE IVF Drugs and Food Supplements Market, by Distribution Channel:

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Buy this Complete Report Now @ https://www.coherentmarketinsights.com/insight/buy-now/4939

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:
Mr. Shah
Senior Client Partner - Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/902389/Coherent_Market_Insights_Logo.jpg

© 2022 PR Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.